Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion type Assertion NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_head.
- NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion description "[The most common genetic alterations in low grade papillary transitional-cell carcinoma (TCC) are loss of heterozygosity of part or all of chromosome 9 and activating mutations of the fibroblast growth factor receptor 3 (FGFR3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_provenance.
- NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion evidence source_evidence_literature NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_provenance.
- NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion SIO_000772 16474624 NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_provenance.
- NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion wasDerivedFrom befree-20140225 NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_provenance.
- NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_assertion wasGeneratedBy ECO_0000203 NP799024.RAx6x5fGWhxinhgFD8bNYSxJmsemFv2m5Eh1QyQwerjIE130_provenance.